trending Market Intelligence /marketintelligence/en/news-insights/trending/3e__qub7bfi0l6a_wuqw2a2 content esgSubNav
In This List

UK's Sinclair Pharma in preliminary takeover talks with Chinese firms

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


UK's Sinclair Pharma in preliminary takeover talks with Chinese firms

U.K.'s Sinclair Pharma PLC said it received a takeover offer from China Grand Enterprises Inc. and its Huadong Medicine Co. Ltd. unit.

According to the pharmaceutical company, discussions are still at a very early stage with no certainty of an acquisition offer being made.

Under the U.K. Takeover Code, the Chinese firms are required to announce their intentions by Aug. 2.

Following news of the potential transaction, Sinclair Pharma's stock price was up 20.31% to 22 pence as of 3:48 p.m. London Time, July 5.

London-based Sinclair Pharma makes and sells dermatological products worldwide.